Cargando…
The risk of angiosarcoma following primary breast cancer
Lymphangiosarcoma of the upper extremity is a rare and aggressive tumour reported to occur following post-mastectomy lymphoedema (Stewart–Treves syndrome). Haemangiosarcoma, a related rare tumour, has occasionally been reported to occur in the breast following irradiation. We conducted a case-contro...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362921/ https://www.ncbi.nlm.nih.gov/pubmed/10507781 http://dx.doi.org/10.1038/sj.bjc.6690726 |
_version_ | 1782153574520717312 |
---|---|
author | Cozen, W Bernstein, L Wang, F Press, M F Mack, T M |
author_facet | Cozen, W Bernstein, L Wang, F Press, M F Mack, T M |
author_sort | Cozen, W |
collection | PubMed |
description | Lymphangiosarcoma of the upper extremity is a rare and aggressive tumour reported to occur following post-mastectomy lymphoedema (Stewart–Treves syndrome). Haemangiosarcoma, a related rare tumour, has occasionally been reported to occur in the breast following irradiation. We conducted a case-control study using the University of Southern California-Cancer Surveillance Program, the population-based cancer registry for Los Angeles County, to evaluate the relationship between invasive female breast cancer and subsequent upper extremity or chest lymphangiosarcoma and haemangiosarcoma together referred to as angiosarcoma. Cases were females diagnosed between 1972 and 1995 with angiosarcoma of the upper extremity (n = 20) or chest (n = 48) who were 25 years of age or older and residing in Los Angeles County when diagnosed. Other sarcomas at the same anatomic sites were also studied. Controls were females diagnosed with cancers other than sarcoma during the same time period (n = 266 444). Cases and controls were then compared with respect to history of a prior invasive epithelial breast cancer. A history of breast cancer increased the risk of upper extremity angiosarcoma by more than 59-fold (odds ratio [OR] = 59.3, 95% confidence interval [95% CI] = 21.9–152.8). A strong increase in risk after breast cancer was also observed for angiosarcoma of the chest and breast (OR = 11.6, 95% CI = 4.3–26.1) and for other sarcomas of the chest and breast (OR = 3.3, 95% CI = 1.1–1.7). © 1999 Cancer Research Campaign |
format | Text |
id | pubmed-2362921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23629212009-09-10 The risk of angiosarcoma following primary breast cancer Cozen, W Bernstein, L Wang, F Press, M F Mack, T M Br J Cancer Regular Article Lymphangiosarcoma of the upper extremity is a rare and aggressive tumour reported to occur following post-mastectomy lymphoedema (Stewart–Treves syndrome). Haemangiosarcoma, a related rare tumour, has occasionally been reported to occur in the breast following irradiation. We conducted a case-control study using the University of Southern California-Cancer Surveillance Program, the population-based cancer registry for Los Angeles County, to evaluate the relationship between invasive female breast cancer and subsequent upper extremity or chest lymphangiosarcoma and haemangiosarcoma together referred to as angiosarcoma. Cases were females diagnosed between 1972 and 1995 with angiosarcoma of the upper extremity (n = 20) or chest (n = 48) who were 25 years of age or older and residing in Los Angeles County when diagnosed. Other sarcomas at the same anatomic sites were also studied. Controls were females diagnosed with cancers other than sarcoma during the same time period (n = 266 444). Cases and controls were then compared with respect to history of a prior invasive epithelial breast cancer. A history of breast cancer increased the risk of upper extremity angiosarcoma by more than 59-fold (odds ratio [OR] = 59.3, 95% confidence interval [95% CI] = 21.9–152.8). A strong increase in risk after breast cancer was also observed for angiosarcoma of the chest and breast (OR = 11.6, 95% CI = 4.3–26.1) and for other sarcomas of the chest and breast (OR = 3.3, 95% CI = 1.1–1.7). © 1999 Cancer Research Campaign Nature Publishing Group 1999-10 /pmc/articles/PMC2362921/ /pubmed/10507781 http://dx.doi.org/10.1038/sj.bjc.6690726 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Cozen, W Bernstein, L Wang, F Press, M F Mack, T M The risk of angiosarcoma following primary breast cancer |
title | The risk of angiosarcoma following primary breast cancer |
title_full | The risk of angiosarcoma following primary breast cancer |
title_fullStr | The risk of angiosarcoma following primary breast cancer |
title_full_unstemmed | The risk of angiosarcoma following primary breast cancer |
title_short | The risk of angiosarcoma following primary breast cancer |
title_sort | risk of angiosarcoma following primary breast cancer |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362921/ https://www.ncbi.nlm.nih.gov/pubmed/10507781 http://dx.doi.org/10.1038/sj.bjc.6690726 |
work_keys_str_mv | AT cozenw theriskofangiosarcomafollowingprimarybreastcancer AT bernsteinl theriskofangiosarcomafollowingprimarybreastcancer AT wangf theriskofangiosarcomafollowingprimarybreastcancer AT pressmf theriskofangiosarcomafollowingprimarybreastcancer AT macktm theriskofangiosarcomafollowingprimarybreastcancer AT cozenw riskofangiosarcomafollowingprimarybreastcancer AT bernsteinl riskofangiosarcomafollowingprimarybreastcancer AT wangf riskofangiosarcomafollowingprimarybreastcancer AT pressmf riskofangiosarcomafollowingprimarybreastcancer AT macktm riskofangiosarcomafollowingprimarybreastcancer |